Therapix Biosciences (TRPXD) Stock Price, News & Analysis

Company Overview

Therapix Biosciences Ltd is a clinical-stage biopharmaceutical company headquartered in Tel Aviv, Israel, with a focus on developing cannabinoid-based therapies to address unmet medical needs in neurology and urology. Since its founding in 2013, the company has built a pipeline of proprietary formulations designed to leverage the therapeutic properties of cannabinoids for conditions such as chronic pain, sexual dysfunction and Tourette’s syndrome.

The company’s lead programs include both oral and topical cannabinoid-derived candidates. Among these is a topical formulation designed to alleviate musculoskeletal pain through localized delivery of cannabidiol, as well as orally administered compounds intended to modulate central nervous system activity for the treatment of anxiety-related symptoms and sexual health disorders. Therapix holds a series of patents and formulations that support its research and development activities, and it has completed several Phase I and Phase II studies to advance its most promising assets.

Therapix conducts its clinical trials and preclinical research in collaboration with contract research organizations and academic institutions across Israel, Europe and North America. The company’s management team comprises professionals with extensive experience in pharmaceutical development, clinical operations and regulatory affairs. Through strategic partnerships and a focus on scientifically driven innovation, Therapix aims to position its cannabinoid-based portfolio for broader commercial development and potential licensing opportunities.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 900 shs
• Average Volume: 1,852 shs
• Market Capitalization: $299 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:TRPXD
• CIK: N/A
• Web: therapixbio.com
• Phone: 972 3 616 7055
• Fax: N/A
• Employees: 8
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.49
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.28 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 50,000
• Free Float: N/A
• Market Cap: $299 thousand
• Optionable: Not Optionable
• Beta: N/A